SPONSOR

University of California, San Francisco

Total Trials

Recruiting

Phases

Phase 2, Phase 4, Phase 1, Phase 3, Phase 1, Phase 2

Conditions studied: Malignant Female Reproductive System Neoplasm Gynecologic Cancer Gynecologic Neoplasm Mucopolysaccharidosis I Mucopolysaccharidosis II Mucopolysaccharidosis IV A Mucopolysaccharidosis VI Mucopolysaccharidosis VII Pompe Disease Infantile-Onset Neuronopathic Gaucher Disease

University of California, San Francisco is a clinical research sponsor with 43 registered studies on ClinicalTrials.gov, of which 43 are actively recruiting participants. Research covers conditions including Malignant Female Reproductive System Neoplasm, Gynecologic Cancer, Gynecologic Neoplasm, Mucopolysaccharidosis I.

The trial portfolio spans Phase 2, Phase 4, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of California, San Francisco

How many clinical trials has University of California, San Francisco sponsored?

ClinicalMetric currently tracks 43 clinical trials sponsored by University of California, San Francisco, of which 43 are actively recruiting participants. These trials cover conditions including Malignant Female Reproductive System Neoplasm, Gynecologic Cancer, Gynecologic Neoplasm. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University of California, San Francisco research focus on?

University of California, San Francisco clinical trials span Malignant Female Reproductive System Neoplasm, Gynecologic Cancer, Gynecologic Neoplasm, Mucopolysaccharidosis I, Mucopolysaccharidosis II, and additional conditions. The research pipeline includes Phase 2, Phase 4, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University of California, San Francisco clinical trial?

To participate in a University of California, San Francisco trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of California, San Francisco trials with current recruitment status updated daily.

University of California, San Francisco

Frequently Asked Questions — University of California, San Francisco

Clinical Trials by University of California, San Francisco

PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery

Registry of Patients Diagnosed With Lysosomal Storage Diseases

Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma

Role of Transposable Elements in Septic Immune Aging

Text Education About Cardiovascular Health and HIV (TEACH-HIV)

Valacyclovir in Pain Management of Acute Apical Abscesses

Effect of Group Preoperative Pelvic Floor Training for HoLEP

A Primary Care Based Intervention to Prevent Childhood Obesity Among Low-income Latino Children

Prehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis

Understanding the Neural Underpinnings of Risk-Taking Behavior in Psychiatric Disease

Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors

Improving Congenital Heart Disease Care

Patient-centered Information on Permanent Contraception

Period Pills for Menstrual Regulation: A New Reproductive Health Option

Intermittent Preventive Treatment of Malaria in School-age Children to Decrease Community Transmission

Trauma-Informed Care for Smoking Cessation for Pregnancy

Chronic Infections and Inflammation in ME/CFS: An Observational Study

Inflammatory Challenge and Fear

Collection of Blood for Multiple Collaborative Studies

Force Sensor Study

Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy

Ancillary Nocturnal Urinary Symptoms Analyses for TRIUMPH

Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration

Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas

Vicryl Rapide Versus Nonabsorbable Suture

Sperm Preparation Prior to Intrauterine Insemination Study

Azithromycin for Child Survival in Niger II

Treatment Outcomes of Esophageal Cancer

An Agricultural Livelihood Intervention for Pregnant Women

Chronic Thromboembolic Disease Registry

Prevention of Mother-to-child Transmission (PMTCT) Among Women Experiencing Depression in Malawi

The Effect of Erector Spinae Plane Block (ESPB) on Pediatric Pain Management Following Posterior Spinal Fusion (PSF) Surgery

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Wearable Activity Tracking to Curb Hospitalizations

UCSF PANC Cyst Registry

Automated Insulin for Management of Intrapartum Glycemia

Mirai-MRI: Validation of AI Models for Breast Cancer Risk

Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer

Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD

Stroke Recovery Initiative - Registry for Stroke Research Studies

Glaucoma Screening to Enhance At-Risk Californians' Health

Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease

Sauna for Offline Connections and Interactive, Authentic Living